ATE368465T1 - Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein - Google Patents

Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein

Info

Publication number
ATE368465T1
ATE368465T1 AT05717490T AT05717490T ATE368465T1 AT E368465 T1 ATE368465 T1 AT E368465T1 AT 05717490 T AT05717490 T AT 05717490T AT 05717490 T AT05717490 T AT 05717490T AT E368465 T1 ATE368465 T1 AT E368465T1
Authority
AT
Austria
Prior art keywords
caffeine
composition containing
linolic acid
containing conjugated
diet composition
Prior art date
Application number
AT05717490T
Other languages
English (en)
Inventor
Bernadette Verneau
Original Assignee
Inst Phytoceutic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Phytoceutic filed Critical Inst Phytoceutic
Application granted granted Critical
Publication of ATE368465T1 publication Critical patent/ATE368465T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05717490T 2004-01-27 2005-01-26 Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein ATE368465T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0400739A FR2865402B1 (fr) 2004-01-27 2004-01-27 Composition amaigrissante par voie orale comprenant de l'acide linoleique conjugue et de la cafeine.

Publications (1)

Publication Number Publication Date
ATE368465T1 true ATE368465T1 (de) 2007-08-15

Family

ID=34717436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05717490T ATE368465T1 (de) 2004-01-27 2005-01-26 Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein

Country Status (10)

Country Link
US (2) US20070269533A1 (de)
EP (1) EP1708716B1 (de)
AT (1) ATE368465T1 (de)
CA (1) CA2554435A1 (de)
DE (1) DE602005001849T2 (de)
DK (1) DK1708716T3 (de)
ES (1) ES2288296T3 (de)
FR (1) FR2865402B1 (de)
PT (1) PT1708716E (de)
WO (1) WO2005082371A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2596311A1 (en) * 2005-01-20 2006-07-27 Stephen Holt Herbal compositions containing hoodia
ES2463090T3 (es) 2005-11-04 2014-05-27 Inqpharm Sdn Bhd Composición a base de plantas para el control del peso
US20090246326A1 (en) * 2008-03-25 2009-10-01 Empty Nest Ideas, Llc Coffee product and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
WO2001060331A2 (en) * 2000-02-15 2001-08-23 Zen-Bio, Inc. Compositions for preventing cellulite in mammalian skin

Also Published As

Publication number Publication date
FR2865402A1 (fr) 2005-07-29
DE602005001849T2 (de) 2007-12-13
WO2005082371A3 (fr) 2006-01-05
DK1708716T3 (da) 2007-10-08
FR2865402B1 (fr) 2006-04-28
ES2288296T3 (es) 2008-01-01
EP1708716B1 (de) 2007-08-01
WO2005082371A2 (fr) 2005-09-09
CA2554435A1 (fr) 2005-09-09
EP1708716A2 (de) 2006-10-11
DE602005001849D1 (de) 2007-09-13
PT1708716E (pt) 2007-10-02
US20100041679A1 (en) 2010-02-18
US20070269533A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
DK1526839T3 (da) Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed
DE60325839D1 (de) Mit 40-o-(2-hydroxy)ethyl-rapamycin beschichteter stent
SG170826A1 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
IL165120A (en) Medical implant with a coating to inhibit infection
CL2007002000A1 (es) Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion.
NO20050060L (no) Medikament for behandling av overaktiv blaere
WO2005094836A3 (en) Use of loteprednol etabonate for the treatment of dry eye
PL375440A1 (en) Sustained release composition for oral administration of drugs
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
WO2005103992A3 (en) Messaging system
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
ATE326968T1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
WO2008128191A3 (en) Oral cephalotaxine dosage forms
DE602004003577D1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
ATE368465T1 (de) Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein
WO2005094265A3 (en) Self assembling activation agents targeted using active drug release
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
AU2002256775A1 (en) Therapeutic method for inducing tolerance
DK1553943T3 (da) Anvendelse af tenatoprazol til behandling af gastroösofageal refluks
NO20050445L (no) Synergistisk interaksjon mellom abacavir og alovudin
EP1582220A4 (de) Zusammensetzung für lokalanästhesie
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
DE50303646D1 (de) Feste pharmazeutische Zusammensetzung enthaltend Tilidinhydrochlorid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1708716

Country of ref document: EP